Posts

Showing posts with the label africa health heathtech fdi investment philantropy people gcc ecosystem builder anjo de heus 360disruption

Real work doesn’t trend as well as the next big idea in a polished deck - By Dr. Anjo De Heus 360disruption.com

Image
A Friday morning thought. #Execution  isn’t sexy. #Proven  solutions are boring. Real work doesn’t trend as well as the next big idea in a polished deck. But execution is what’s actually needed. Across  #Africa , I see enormous  #energy  around  #opportunity  — new  #alliances , new  #councils , new  #narratives . AND alongside that, I see people quietly deploying solutions that already work: building  #clinics , running  #diagnostics ,  #training  teams, fixing  #systems , staying when it’s hard. The gap isn’t  #vision . It’s follow-through. We don’t lack  #innovation . We lack  #disciplined  deployment at scale. #Sustainable   #impact  rarely comes from what’s new. It comes from what’s tested, adaptable, and repeatable — implemented with patience and accountability. This isn’t anti-innovation. It’s pro-outcomes. Maybe it’s time we made execution a little more  #attractive ...

From Distressed Assets to Sovereign Capability — Thought Leadership by Dr. Anjo De Heus

Image
Why Africa’s Biotech Future May Be Built, Not Invented** Over the past weeks, I’ve been looking closely at something that doesn’t get nearly enough attention in global health and development conversations:  distressed biotech and pharmaceutical assets . In the United States and Europe, there are dozens of biotech and pharma companies sitting in various states of distress — not because the science failed, but because capital cycles shifted, timelines stretched, or strategic priorities changed. Some are in restructuring. Some in bankruptcy. Others are quietly being carved up for parts. What’s striking is this:  many of these assets still work . They have IP. They have data. They have GMP-grade processes, equipment, or know-how. They are not dead. They are simply  orphaned . At the same time, Africa — a continent of more than 1.4 billion people — remains overwhelmingly dependent on imports for essential medicines, biologics, diagnostics, and APIs. Not because of a lack of ta...

Why Africa’s Fastest Path to Scale Is Building Ecosystems Around Proven Solutions — A honest opinion from Anjo De Heus

Image
  Stop Starting From Scratch: Why Africa’s Fastest Path to Scale Is Building Ecosystems Around Proven Solutions — A honest opinion from Anjo De Heus For decades, Africa’s entrepreneurship narrative has been dominated by one idea:  startups from scratch . New founders. New ideas. New pilots. New incubators. And yet, the results remain stubbornly familiar: promising pilots, underfunded scale, and ecosystems that never quite tip into self-sustainability. What if the real problem isn’t a lack of innovation — but  where we choose to start ? The Hard Truth Africa does not suffer from a shortage of ideas. It suffers from a shortage of  execution systems . Too many ventures are built as isolated projects: A product without distribution A startup without sovereign alignment A pilot without manufacturing A founder without institutional backing This is why even “successful” pilots struggle to scale beyond donor cycles. A Different Starting Point The fastest way to build scalabl...